BioInno

Beijing, China · Founded 2019 · Privately Held (backing)

Provider of CDMO process development and GMP production services for cell culture, bioprocessing, and biologics-related technical applications. BioInno is based in Beijing, China and was founded in 2019. Its last reported valuation was $156 million in Dec 2021. It has raised $48.1 million.

Last reported valuation
$156.4M
Oct 2026
Priced at
—
Total raised
$48.1M
Last round
—

Who backs BioInno?

13 investors
InvestorType
Shenzhen Yifeng Investment Management EnterpriseVenture capital
Tailong VCOther
Orient Securities Capital Investment CompanyOther
Ciit Asset ManagementOther
HJ-InvestmentOther
Ao Peng Investment—
BridgeOne Capital China—
Hangzhou Tigermed Consulting Company—
Origins Capital—
Suzhou Cross Currents Capital Management—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioInno investors

Free account
More of BioInno with a free account
  • ·The complete investor list: 13 names
  • ·Watch BioInno: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like BioInno. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View